Literature DB >> 2935223

Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro.

H Coirini, A M Magariños, A F De Nicola, T C Rainbow, B S McEwen.   

Abstract

We have used synthetic markers of the glucocorticoid (GC) receptor (RU 28362) and of the mineralocorticoid (MC) receptors (RU 26752 and RU 28318) to characterize the specificity of the sites binding aldosterone (ALDO), dexamethasone (DEX) and corticosterone (CORT) in cytosol of hippocampus. The results obtained suggest that ALDO was bound mostly to a MC receptor, as the relative binding affinity (RBA) of the GC receptor marker (and that of the previously studied RU 26988) was negligible for this site, in contrast to the high RBA displayed by RU 26752. DEX was bound for a large part to a GC receptor, as RU 28362 competed for this site, although the MC receptor marker still showed some affinity. An intermediate effect of both marker types was obtained with CORT. RU 28318 was a weak competitor for either the GC or the MC binding site. Thus, RU 28362 and RU 26752 allowed the discrimination of two to three receptors in the hippocampus, similarly to those described in the kidney. Finally, we have demonstrated the usefulness of these synthetic markers in identifying MC binding sites in several brain regions and also in the hippocampus during ontogenetic development.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935223     DOI: 10.1016/0006-8993(85)91291-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

Review 1.  Adrenocorticoid action in the spinal cord: some unique molecular properties of glucocorticoid receptors.

Authors:  A F De Nicola; D F Moses; S González; E Ortí
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

Review 2.  Aldosterone in the brain.

Authors:  Joel C Geerling; Arthur D Loewy
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-04

Review 3.  Corticosteroids in the brain. Cellular and molecular actions.

Authors:  M Joëls; E Vreugdenhil
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

Review 4.  [Corticosteroids in the management of advanced prostate cancer].

Authors:  H Kübler
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

Review 5.  Corticosteroid receptor antagonists: a current perspective.

Authors:  W Sutanto; E R de Kloet
Journal:  Pharm World Sci       Date:  1995-03-24

Review 6.  Functional implications of brain corticosteroid receptor diversity.

Authors:  E R de Kloet; M S Oitzl; M Joëls
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

7.  The 21-aminosteroid U-74389F increases the number of glial fibrillary acidic protein-expressing astrocytes in the spinal cord of control and Wobbler mice.

Authors:  M C Gonzalez Deniselle; S L Gonzalez; G G Piroli; A E Lima; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  1996-02       Impact factor: 5.046

8.  Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation.

Authors:  M M Sánchez; L J Young; P M Plotsky; T R Insel
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

9.  Effects of deoxycorticosterone treatment on beta-subunit mRNA for (Na + K)ATPase in brain regions determined by in situ hybridization.

Authors:  C Grillo; S Vallee; G Piroli; J A Angulo; B S McEwen; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  1991-06       Impact factor: 5.046

Review 10.  Ontogeny of corticosteroid receptors in the brain.

Authors:  P Rosenfeld; J A van Eekelen; S Levine; E R de Kloet
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.